[ 18F]fluoroacetate positron emission tomography for hepatocellular carcinoma and metastases: An alternative tracer for [ 11c]acetate?

Molecular Imaging

Volumn 11, Issue 3, 2012, Pages 229-239

  Ho, Chi Lai ^a,b   Cheung, Man Ki ^a,b   Chen, Sirong ^a,b   Cheung, Tan To ^a,b   Leung, Yim Lung ^a,b   Cheng, Kam Chau ^a,b   Yeung, Wing Ding ^a,b  

^a HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BIODISTRIBUTIONS; DEFLUORINATION; FLUOROACETATE; HEPATOCELLULAR CARCINOMA; HUMAN SUBJECTS; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES; POSTINJECTION; RADIOCHEMICAL PURITY; REACTION YIELDS; SEMI-QUANTITATIVE ANALYSIS; STATISTICAL CORRELATION; SYNTHESIS TIME; TUMOR UPTAKE; WHOLE-BODY;

DIAGNOSIS; SYNTHESIS (CHEMICAL); VOLATILE FATTY ACIDS;

POSITRON EMISSION TOMOGRAPHY;

DIAGNOSTIC AGENT; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METASTASIS; METHODOLOGY; PATHOLOGY; SCINTISCANNING; TISSUE DISTRIBUTION;

CARCINOMA, HEPATOCELLULAR; FLUORINE RADIOISOTOPES; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 84862661268     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2011.00043     Document Type: Article

References (16)

1. Oyama N, Miller TR, Dehdashti F, et al. 11C-Acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med 2003;44:549-55. (Pubitemid 39663421)
2. Shreve P, Chiao PC, Humes HD, et al. Carbon-11-acetate PET imaging in renal disease. J Nucl Med 1995;36:1595-601.
3. Ho CL, Yu SC, Yeung DW. 11C-Acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 2003;44:213-21.
4. Nomori H, Kosaka N, Watanabe K, et al. 11C-Acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography. Ann Thorac Surg 2005;80:2020-5, doi:10.1016/j.athoracsur.2005.06.003. (Pubitemid 41718021)
5. Nishii R, Tong W, Wendt R 3rd, et al. Pharmacokinetics, metabolism, biodistribution, radiation dosimetry, and toxicology of (18) F-fluoroacetate ((18) F-FACE) in non-human primates. Mol Imaging Biol 2011 Mar. 25. [Epub ahead of print]
6. Jeong JM, Lee DS, Chung JK, et al. Synthesis of no-carrier-added [18F]fluoroacetate. J Lab Compd Radiopharm 1997;34:395-9, doi:10.1002/(SICI) 1099-1344 (199705) 39:5, 395::AID-JLCR985.3.0. CO; 2-4.
7. Sun LQ, Mori T, Dence CS, et al. New approach to fully automated synthesis of sodium [18F]fluoroacetate-a simple and fast method using a commercial synthesizer. Nucl Med Biol 2006;33:153-8, doi:10.1016/j.nucmedbio. 2005.07.005. (Pubitemid 43184090)
8. Ponde DE, Dence CS, Oyama N, et al. 18F-Fluoroacetate: a potential acetate analog for prostate tumor imaging-in vivo evaluation of 18F-fluoroacetate versus 11C-acetate. J Nucl Med 2007;48:420-8. (Pubitemid 47604928)
9. Richter S, Bergmann R, Pietzsch J, et al. [18F]Fluoroacetate and radiopharmacological characterization in rats and tumor-xenografted mice. Curr Radiopharm 2008;1:103-9, doi:10.2174/1874471010801020103.
10. Sewell PA, Clarke B. Chromatographic separations analytical chemistry by opening learning. New Jersey: John Wiley & Sons; 1991.
11. Meyer VR. Pitfalls and errors of HPLC in pictures. Part I: Fundamentals. 1.17: Noise. Weinheim, Germany: Wiley-VCH Verlag GmbH; 2006.
12. Goncharov NV, Jenkins RO, Radilov AS. Toxicology of fluoroacetate: a review, with possible directions for therapy research. J Appl Toxicol 2006;26:148-61, doi:10.1002/jat.1118.
13. Ho CL, Cheng T K C, Yeung D W C. 11C-Acetate PET imaging in the differentiation of renal angiomyolipoma and renal cell carcinoma. J Nucl Med 2005;46:46P.
14. Lindhe O, Sun A, Ulin J, et al. [(18) F]Fluoroacetate is not a functional analogue of [(11) C]acetate in normal physiology. Eur J Nucl Med Mol Imaging 2009;36:1453-9, doi:10.1007/s00259-009-1128-7.
15. Matthies A, Ezziddin S, Ulrich EM, et al. Imaging of prostate cancer metastases with 18F-fluoroacetate using PET/CT. Eur J Nucl Med Mol Imaging 2004;31:797, doi:10.1007/s00259-003-1437-1. (Pubitemid 38647921)
16. Peters R. Some metabolic aspects of fluoroacetate especially related to fluorocitrate. Ciba Found Symp 1971;2:55-76.